Nepal approved on Thursday the emergency use of a Covid-19 vaccine developed by an affiliate of China’s Sinopharm, a government official said, the second vaccine cleared after Oxford-AstraZeneca’s product. The move paves the way for China to donate 500,000 doses of the Sinopharm vaccine to the Himalayan nation, which last month received one million AstraZeneca doses from India.